CRISPR THERAPEUTICS AG's ticker is and the CUSIP is H17182908. A total of 6 filers reported holding CRISPR THERAPEUTICS AG in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,938,711 | -63.6% | 174,900 | -55.0% | 0.00% | -57.1% |
| Q2 2023 | $21,816,004 | +108.4% | 388,600 | +67.9% | 0.01% | +75.0% |
| Q1 2023 | $10,466,222 | +0.4% | 231,400 | -9.8% | 0.00% | -20.0% |
| Q4 2022 | $10,426,725 | -62.9% | 256,500 | -40.4% | 0.01% | -58.3% |
| Q3 2022 | $28,120,000 | +9.5% | 430,300 | +1.8% | 0.01% | +9.1% |
| Q2 2022 | $25,675,000 | – | 422,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 444,300 | $68,027,000 | 0.12% |
| Marathon Trading Investment Management LLC | 3,400 | $521,000 | 0.03% |
| SIMPLEX TRADING, LLC | 935 | $14,315,000 | 0.02% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |